Thetis Pharmaceuticals LLC
Leveraging existing active pharmaceutical ingredients to chemically create new molecular entities with enhanced PK and efficacy
Founded in January 2011, Thetis is an emerging pharmaceutical company developing a portfolio of prescription drugs for the treatment of type 2 diabetes, hypertriglyceridemia and dyslipidemia. All have blockbuster potential as first-in-class or best-in-class opportunities in major pharmaceutical markets. EPA, a principal active ingredient in omega-3 fatty acids, is uniquely incorporated into the chemical structures of the Thetis compounds.